Skip to content

Public FDA record

Z-0086-2010: Ortho Development Corp., Pivot BiPolar Head, 28mm, Hip Prosthesis, Femoral Head.

Recall record Z-0086-2010 for Ortho Development Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0086-2010
Company in FDA record
Ortho Development Corporation
FDA classification date
Oct 28, 2009
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

A Pivot BiPolar Head, the femoral head in a hip prosthesis, might not move freely after assembly due a stacking up of manufacturing tolerances.

Source facts

Action
Ortho sent a Field notification Memo dated 4/2/2009 to agents and distributors, giving them pre-implant examination guidelines. Decision to recall non-implanted units was made on 4/29/2009 and this was communicated by telephone to distributors.
Initiated
2009-04-29
Root cause
Device Design
Terminated
2010-05-25
Distribution
AZ, CA, FL, MA, MI. No military, government or foreign distribution.
Recall number
Z-0086-2010
Recall status
Terminated
CDRH record ID
81990
FDA classified
2009-10-28
Recall event number
52048

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗